Global PEGylated Protein Therapeutics Market Research Report 2023

Report ID: 1983370 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global PEGylated Protein Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Colony Stimulating Factor
        1.2.3 Interferon
        1.2.4 Erythropoietin (EPO)
        1.2.5 Recombinant Factor VIII
        1.2.6 Monoclonal Antibody
        1.2.7 Enzyme
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global PEGylated Protein Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Cancer
        1.3.3 Autoimmune Disease
        1.3.4 Hepatitis
        1.3.5 Multiple Sclerosis
        1.3.6 Hemophilia
        1.3.7 Gastrointestinal Disorder
        1.3.8 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global PEGylated Protein Therapeutics Market Perspective (2017-2028)
    2.2 PEGylated Protein Therapeutics Growth Trends by Region
        2.2.1 PEGylated Protein Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 PEGylated Protein Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 PEGylated Protein Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 PEGylated Protein Therapeutics Market Dynamics
        2.3.1 PEGylated Protein Therapeutics Industry Trends
        2.3.2 PEGylated Protein Therapeutics Market Drivers
        2.3.3 PEGylated Protein Therapeutics Market Challenges
        2.3.4 PEGylated Protein Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top PEGylated Protein Therapeutics Players by Revenue
        3.1.1 Global Top PEGylated Protein Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global PEGylated Protein Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global PEGylated Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by PEGylated Protein Therapeutics Revenue
    3.4 Global PEGylated Protein Therapeutics Market Concentration Ratio
        3.4.1 Global PEGylated Protein Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by PEGylated Protein Therapeutics Revenue in 2021
    3.5 PEGylated Protein Therapeutics Key Players Head office and Area Served
    3.6 Key Players PEGylated Protein Therapeutics Product Solution and Service
    3.7 Date of Enter into PEGylated Protein Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 PEGylated Protein Therapeutics Breakdown Data by Type
    4.1 Global PEGylated Protein Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global PEGylated Protein Therapeutics Forecasted Market Size by Type (2023-2028)
5 PEGylated Protein Therapeutics Breakdown Data by Application
    5.1 Global PEGylated Protein Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global PEGylated Protein Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America PEGylated Protein Therapeutics Market Size (2017-2028)
    6.2 North America PEGylated Protein Therapeutics Market Size by Country (2017-2022)
    6.3 North America PEGylated Protein Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe PEGylated Protein Therapeutics Market Size (2017-2028)
    7.2 Europe PEGylated Protein Therapeutics Market Size by Country (2017-2022)
    7.3 Europe PEGylated Protein Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific PEGylated Protein Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific PEGylated Protein Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific PEGylated Protein Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America PEGylated Protein Therapeutics Market Size (2017-2028)
    9.2 Latin America PEGylated Protein Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America PEGylated Protein Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa PEGylated Protein Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa PEGylated Protein Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa PEGylated Protein Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck PEGylated Protein Therapeutics Introduction
        11.1.4 Merck Revenue in PEGylated Protein Therapeutics Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer PEGylated Protein Therapeutics Introduction
        11.2.4 Pfizer Revenue in PEGylated Protein Therapeutics Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 UCB
        11.3.1 UCB Company Detail
        11.3.2 UCB Business Overview
        11.3.3 UCB PEGylated Protein Therapeutics Introduction
        11.3.4 UCB Revenue in PEGylated Protein Therapeutics Business (2017-2022)
        11.3.5 UCB Recent Development
    11.4 Amgen
        11.4.1 Amgen Company Detail
        11.4.2 Amgen Business Overview
        11.4.3 Amgen PEGylated Protein Therapeutics Introduction
        11.4.4 Amgen Revenue in PEGylated Protein Therapeutics Business (2017-2022)
        11.4.5 Amgen Recent Development
    11.5 AstraZeneca
        11.5.1 AstraZeneca Company Detail
        11.5.2 AstraZeneca Business Overview
        11.5.3 AstraZeneca PEGylated Protein Therapeutics Introduction
        11.5.4 AstraZeneca Revenue in PEGylated Protein Therapeutics Business (2017-2022)
        11.5.5 AstraZeneca Recent Development
    11.6 Biogen
        11.6.1 Biogen Company Detail
        11.6.2 Biogen Business Overview
        11.6.3 Biogen PEGylated Protein Therapeutics Introduction
        11.6.4 Biogen Revenue in PEGylated Protein Therapeutics Business (2017-2022)
        11.6.5 Biogen Recent Development
    11.7 Roche
        11.7.1 Roche Company Detail
        11.7.2 Roche Business Overview
        11.7.3 Roche PEGylated Protein Therapeutics Introduction
        11.7.4 Roche Revenue in PEGylated Protein Therapeutics Business (2017-2022)
        11.7.5 Roche Recent Development
    11.8 Horizon Pharma
        11.8.1 Horizon Pharma Company Detail
        11.8.2 Horizon Pharma Business Overview
        11.8.3 Horizon Pharma PEGylated Protein Therapeutics Introduction
        11.8.4 Horizon Pharma Revenue in PEGylated Protein Therapeutics Business (2017-2022)
        11.8.5 Horizon Pharma Recent Development
    11.9 Leadiant Biosciences
        11.9.1 Leadiant Biosciences Company Detail
        11.9.2 Leadiant Biosciences Business Overview
        11.9.3 Leadiant Biosciences PEGylated Protein Therapeutics Introduction
        11.9.4 Leadiant Biosciences Revenue in PEGylated Protein Therapeutics Business (2017-2022)
        11.9.5 Leadiant Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global PEGylated Protein Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Colony Stimulating Factor
    Table 3. Key Players of Interferon
    Table 4. Key Players of Erythropoietin (EPO)
    Table 5. Key Players of Recombinant Factor VIII
    Table 6. Key Players of Monoclonal Antibody
    Table 7. Key Players of Enzyme
    Table 8. Key Players of Others
    Table 9. Global PEGylated Protein Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global PEGylated Protein Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global PEGylated Protein Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global PEGylated Protein Therapeutics Market Share by Region (2017-2022)
    Table 13. Global PEGylated Protein Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global PEGylated Protein Therapeutics Market Share by Region (2023-2028)
    Table 15. PEGylated Protein Therapeutics Market Trends
    Table 16. PEGylated Protein Therapeutics Market Drivers
    Table 17. PEGylated Protein Therapeutics Market Challenges
    Table 18. PEGylated Protein Therapeutics Market Restraints
    Table 19. Global PEGylated Protein Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global PEGylated Protein Therapeutics Market Share by Players (2017-2022)
    Table 21. Global Top PEGylated Protein Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEGylated Protein Therapeutics as of 2021)
    Table 22. Ranking of Global Top PEGylated Protein Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by PEGylated Protein Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players PEGylated Protein Therapeutics Product Solution and Service
    Table 26. Date of Enter into PEGylated Protein Therapeutics Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global PEGylated Protein Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global PEGylated Protein Therapeutics Revenue Market Share by Type (2017-2022)
    Table 30. Global PEGylated Protein Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global PEGylated Protein Therapeutics Revenue Market Share by Type (2023-2028)
    Table 32. Global PEGylated Protein Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global PEGylated Protein Therapeutics Revenue Market Share by Application (2017-2022)
    Table 34. Global PEGylated Protein Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global PEGylated Protein Therapeutics Revenue Market Share by Application (2023-2028)
    Table 36. North America PEGylated Protein Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America PEGylated Protein Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe PEGylated Protein Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Europe PEGylated Protein Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Asia-Pacific PEGylated Protein Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 41. Asia-Pacific PEGylated Protein Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 42. Latin America PEGylated Protein Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Latin America PEGylated Protein Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Middle East & Africa PEGylated Protein Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Middle East & Africa PEGylated Protein Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Merck Company Detail
    Table 47. Merck Business Overview
    Table 48. Merck PEGylated Protein Therapeutics Product
    Table 49. Merck Revenue in PEGylated Protein Therapeutics Business (2017-2022) & (US$ Million)
    Table 50. Merck Recent Development
    Table 51. Pfizer Company Detail
    Table 52. Pfizer Business Overview
    Table 53. Pfizer PEGylated Protein Therapeutics Product
    Table 54. Pfizer Revenue in PEGylated Protein Therapeutics Business (2017-2022) & (US$ Million)
    Table 55. Pfizer Recent Development
    Table 56. UCB Company Detail
    Table 57. UCB Business Overview
    Table 58. UCB PEGylated Protein Therapeutics Product
    Table 59. UCB Revenue in PEGylated Protein Therapeutics Business (2017-2022) & (US$ Million)
    Table 60. UCB Recent Development
    Table 61. Amgen Company Detail
    Table 62. Amgen Business Overview
    Table 63. Amgen PEGylated Protein Therapeutics Product
    Table 64. Amgen Revenue in PEGylated Protein Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. Amgen Recent Development
    Table 66. AstraZeneca Company Detail
    Table 67. AstraZeneca Business Overview
    Table 68. AstraZeneca PEGylated Protein Therapeutics Product
    Table 69. AstraZeneca Revenue in PEGylated Protein Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. AstraZeneca Recent Development
    Table 71. Biogen Company Detail
    Table 72. Biogen Business Overview
    Table 73. Biogen PEGylated Protein Therapeutics Product
    Table 74. Biogen Revenue in PEGylated Protein Therapeutics Business (2017-2022) & (US$ Million)
    Table 75. Biogen Recent Development
    Table 76. Roche Company Detail
    Table 77. Roche Business Overview
    Table 78. Roche PEGylated Protein Therapeutics Product
    Table 79. Roche Revenue in PEGylated Protein Therapeutics Business (2017-2022) & (US$ Million)
    Table 80. Roche Recent Development
    Table 81. Horizon Pharma Company Detail
    Table 82. Horizon Pharma Business Overview
    Table 83. Horizon Pharma PEGylated Protein Therapeutics Product
    Table 84. Horizon Pharma Revenue in PEGylated Protein Therapeutics Business (2017-2022) & (US$ Million)
    Table 85. Horizon Pharma Recent Development
    Table 86. Leadiant Biosciences Company Detail
    Table 87. Leadiant Biosciences Business Overview
    Table 88. Leadiant Biosciences PEGylated Protein Therapeutics Product
    Table 89. Leadiant Biosciences Revenue in PEGylated Protein Therapeutics Business (2017-2022) & (US$ Million)
    Table 90. Leadiant Biosciences Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global PEGylated Protein Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Colony Stimulating Factor Features
    Figure 3. Interferon Features
    Figure 4. Erythropoietin (EPO) Features
    Figure 5. Recombinant Factor VIII Features
    Figure 6. Monoclonal Antibody Features
    Figure 7. Enzyme Features
    Figure 8. Others Features
    Figure 9. Global PEGylated Protein Therapeutics Market Share by Application in 2021 & 2028
    Figure 10. Cancer Case Studies
    Figure 11. Autoimmune Disease Case Studies
    Figure 12. Hepatitis Case Studies
    Figure 13. Multiple Sclerosis Case Studies
    Figure 14. Hemophilia Case Studies
    Figure 15. Gastrointestinal Disorder Case Studies
    Figure 16. Others Case Studies
    Figure 17. PEGylated Protein Therapeutics Report Years Considered
    Figure 18. Global PEGylated Protein Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 19. Global PEGylated Protein Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 20. Global PEGylated Protein Therapeutics Market Share by Region: 2021 VS 2028
    Figure 21. Global PEGylated Protein Therapeutics Market Share by Players in 2021
    Figure 22. Global Top PEGylated Protein Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEGylated Protein Therapeutics as of 2021)
    Figure 23. The Top 10 and 5 Players Market Share by PEGylated Protein Therapeutics Revenue in 2021
    Figure 24. North America PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. North America PEGylated Protein Therapeutics Market Share by Country (2017-2028)
    Figure 26. United States PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Canada PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Europe PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Europe PEGylated Protein Therapeutics Market Share by Country (2017-2028)
    Figure 30. Germany PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific PEGylated Protein Therapeutics Market Share by Region (2017-2028)
    Figure 38. China PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Latin America PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Latin America PEGylated Protein Therapeutics Market Share by Country (2017-2028)
    Figure 46. Mexico PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa PEGylated Protein Therapeutics Market Share by Country (2017-2028)
    Figure 50. Turkey PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia PEGylated Protein Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Merck Revenue Growth Rate in PEGylated Protein Therapeutics Business (2017-2022)
    Figure 53. Pfizer Revenue Growth Rate in PEGylated Protein Therapeutics Business (2017-2022)
    Figure 54. UCB Revenue Growth Rate in PEGylated Protein Therapeutics Business (2017-2022)
    Figure 55. Amgen Revenue Growth Rate in PEGylated Protein Therapeutics Business (2017-2022)
    Figure 56. AstraZeneca Revenue Growth Rate in PEGylated Protein Therapeutics Business (2017-2022)
    Figure 57. Biogen Revenue Growth Rate in PEGylated Protein Therapeutics Business (2017-2022)
    Figure 58. Roche Revenue Growth Rate in PEGylated Protein Therapeutics Business (2017-2022)
    Figure 59. Horizon Pharma Revenue Growth Rate in PEGylated Protein Therapeutics Business (2017-2022)
    Figure 60. Leadiant Biosciences Revenue Growth Rate in PEGylated Protein Therapeutics Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Pfizer
UCB
Amgen
AstraZeneca
Biogen
Roche
Horizon Pharma
Leadiant Biosciences
Frequently Asked Questions
PEGylated Protein Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
PEGylated Protein Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
PEGylated Protein Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

SPECT Scanners

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More